RGT — Argent BioPharma Share News
0.000.00%
- AU$3.56m
- AU$3.48m
- AU$0.16m
Brief: Argent Biopharma Seeks Trading Halt
Additional Information for Shareholders
Brief: Argent Biopharma Ltd To Delist from London Stock Exchange
Brief: Argent Biopharma Announces Intention To Delist From London Stock Exchange
September 2024 Quarterly Report
Dispatch of Annual General Meeting Documents
Placing to Raise A$200,000
Holding(s) in Company
Director/PDMR Shareholding
Refinancing of Convertible Security Agreement
Annual Report for the year ended 30 June 2024
Date of AGM & Closing Date of Director Nominations
ASX Delisting Update
Director/PDMR Shareholding
CannEpil - Technical Overview
CimetrA - Technical Overview
30 June 2024 Preliminary Financial Report
Notice of General Meeting
SINTEF Collaboration for Chronic Wound Management